Literature DB >> 25663475

Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.

Kotaro Tsuboi1, Kei Nakai, Chiharu Iwahashi, Fumi Gomi, Yasushi Ikuno, Kohji Nishida.   

Abstract

PURPOSE: To characterize patients with Vogt-Koyanagi-Harada (VKH) disease with choroidal folds (CFs) and determine how the foveal choroidal thickness changes after initial treatment using high-penetration optical coherence tomography (HP-OCT).
METHODS: In this retrospective observational study, we analyzed 42 eyes of 21 patients with new-onset VKH disease to determine the demographic and clinical differences between patients with and without CFs.
RESULTS: Twenty-four eyes (57.1 %) of 13 patients with VKH disease had CFs. The mean age (p = 0.0009) of patients with CFs was significantly higher than that of those without CFs (49.1 vs 39.4 years respectively). The frequency of disc swelling (p = 0.0001) was significantly higher in eyes with CFs than in those without CFs (95.8 % vs 38.9 %). The choroidal thickness at the first visit (p = 0.0011) was significantly greater in eyes with CFs than in those without CFs (794 ± 144 μm vs 649 ± 113 μm). The choroid 6 months after the initial treatment (p = 0.0118) was significantly thinner in eyes with CFs than in those without CFs (270 ± 92 μm vs 340 ± 80 μm). The frequency of sunset glow fundus at 6 months (p = 0.0334) in eyes with CFs was significantly higher than in those without CFs (62.5 % vs 27.8 %).
CONCLUSION: The development of CFs in patients with VKH disease was significantly correlated with age, disc swelling, and choroidal thickness. The eyes with CFs frequently developed a sunset glow fundus. The findings suggested that patients with CFs might have severe and longstanding inflammation of the choroidal tissues.

Entities:  

Mesh:

Year:  2015        PMID: 25663475     DOI: 10.1007/s00417-015-2945-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography.

Authors:  Yasushi Ikuno; Yasuo Tano
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-11       Impact factor: 4.799

Review 2.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

3.  The origin of choroidal folds a clinical, histopathological, and experimental study.

Authors:  J D Bullock; P R Egbert
Journal:  Doc Ophthalmol       Date:  1974-11       Impact factor: 2.379

4.  Retinal pigment epithelium folds as a diagnostic finding of Vogt-Koyanagi-Harada disease.

Authors:  Yoshitake Kato; Yumiko Yamamoto; Hitoshi Tabuchi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2012-11-14       Impact factor: 2.447

5.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

6.  Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.

Authors:  Peizeng Yang; Yalin Ren; Bing Li; Wang Fang; Qianli Meng; Aize Kijlstra
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

7.  Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease.

Authors:  Vishali Gupta; Amod Gupta; Pawan Gupta; Aman Sharma
Journal:  Am J Ophthalmol       Date:  2008-10-02       Impact factor: 5.258

8.  Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.

Authors:  Hossein Nazari; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2012-08-31       Impact factor: 4.638

9.  Vogt-Koyanagi-Harada disease in elderly Japanese patients.

Authors:  Chihiro Kiyomoto; Masamoto Imaizumi; Kenichi Kimoto; Hiromi Abe; Satoko Nakano; Kazuo Nakatsuka
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.029

10.  Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease.

Authors:  Christine Fardeau; Thi Ha Chau Tran; Badra Gharbi; Nathalie Cassoux; Bahram Bodaghi; Phuc LeHoang
Journal:  Int Ophthalmol       Date:  2007-02-02       Impact factor: 2.029

View more
  4 in total

1.  Optical coherence tomography angiography in incomplete acute Vogt-Koyanagi-Harada disease.

Authors:  Gilda Cennamo; Mario R Romano; Claudio Iovino; Giuseppe de Crecchio; Giovanni Cennamo
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

Review 2.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

3.  Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease.

Authors:  M Zhou; R P Gu; Z Sun; C H Jiang; Q Chang; G Z Xu
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

Review 4.  Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.

Authors:  Cristhian A Urzua; Carl P Herbort; Masaru Takeuchi; Ariel Schlaen; Luz E Concha-Del-Rio; Yoshihiko Usui; Loreto Cuitino; Ioannis Papasavvas
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.